Judges Scientific plc (AIM:JDG)
London · Delayed Price · Currency is GBP · Price in GBX 3,975.00
-25.00 (-0.63%)
Aug 17, 2026, 11:00 AM GMT
Judges Scientific Income Statement
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 145.8 | 133.6 | 136.1 | 113.2 | 91.29 | |
Revenue Growth | 9.13% | -1.84% | 20.23% | 24.00% | 14.30% |
Cost of Revenue | 46.2 | 42.9 | 42.5 | 36.9 | 33.88 |
Gross Profit | 99.6 | 90.7 | 93.6 | 76.3 | 57.41 |
Selling, General & Admin | 67.5 | 59.9 | 56.3 | 44.3 | 37.36 |
Amortization of Goodwill & Intangibles | 15.1 | 10.1 | 12.2 | 8.5 | 2.65 |
Other Operating Expenses | 0.3 | - | - | -0.1 | 0.09 |
Operating Expenses | 87.2 | 73.7 | 71.7 | 55.2 | 42.2 |
Operating Income | 12.4 | 17 | 21.9 | 21.1 | 15.21 |
Interest Expense | -5.6 | -4 | -4.7 | 0.2 | -0.71 |
Interest & Investment Income | 0.6 | 0.4 | 0.4 | 0.2 | 0 |
Other Non Operating Income (Expenses) | 0.2 | -0.1 | - | 0.1 | 0.19 |
EBT Excluding Unusual Items | 7.6 | 13.3 | 17.6 | 21.6 | 14.69 |
Merger & Restructuring Charges | -0.7 | -0.3 | -0.2 | -3 | 0.02 |
Other Unusual Items | 2 | - | -4 | -2.6 | 0.16 |
Pretax Income | 8.9 | 13 | 13.4 | 16 | 14.86 |
Income Tax Expense | 2.9 | 2.2 | 3.5 | 3.2 | 1.96 |
Earnings From Continuing Operations | 6 | 10.8 | 9.9 | 12.8 | 12.9 |
Minority Interest in Earnings | -0.5 | -0.4 | -0.4 | -0.3 | -0.22 |
Net Income | 5.5 | 10.4 | 9.5 | 12.5 | 12.68 |
Net Income to Common | 5.5 | 10.4 | 9.5 | 12.5 | 12.68 |
Net Income Growth | -47.12% | 9.47% | -24.00% | -1.44% | 54.28% |
Shares Outstanding (Basic) | 7 | 7 | 7 | 6 | 6 |
Shares Outstanding (Diluted) | 7 | 7 | 7 | 6 | 6 |
Shares Change | 0.10% | 1.90% | 3.00% | 0.46% | 0.18% |
EPS (Basic) | 0.83 | 1.57 | 1.46 | 1.97 | 2.01 |
EPS (Diluted) | 0.81 | 1.54 | 1.43 | 1.94 | 1.98 |
EPS Growth | -47.21% | 7.46% | -25.84% | -2.37% | 54.00% |
Additional Metrics
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 24.2 | 23.5 | 21.8 | 15.5 | 14.75 |
Free Cash Flow Per Share | 3.58 | 3.48 | 3.29 | 2.41 | 2.31 |
Dividend Per Share | 1.150 | 1.045 | 0.950 | 0.810 | 0.660 |
Dividend Growth | 10.05% | 10.00% | 17.28% | 22.73% | 20.00% |
Gross Margin | 68.31% | 67.89% | 68.77% | 67.40% | 62.89% |
Operating Margin | 8.51% | 12.72% | 16.09% | 18.64% | 16.66% |
Profit Margin | 3.77% | 7.78% | 6.98% | 11.04% | 13.89% |
Free Cash Flow Margin | 16.60% | 17.59% | 16.02% | 13.69% | 16.15% |
EBITDA | 29.2 | 28.6 | 35.6 | 30.9 | 18.88 |
EBITDA Margin | 20.03% | 21.41% | 26.16% | 27.30% | 20.69% |
D&A For EBITDA | 16.8 | 11.6 | 13.7 | 9.8 | 3.68 |
EBIT | 12.4 | 17 | 21.9 | 21.1 | 15.21 |
EBIT Margin | 8.51% | 12.72% | 16.09% | 18.64% | 16.66% |
Effective Tax Rate | 32.58% | 16.92% | 26.12% | 20.00% | 13.16% |